STING1 and Alzheimer disease: Moreover, optimizing drug delivery systems, such as nanoparticle-based carriers, carrier/receptor-mediated endocytosis, and exosome-mediated drug delivery [273–276], may offer breakthroughs in targeting the cGAS-STING pathway for AD treatment.